Citron Research, the firm led by short-seller Andrew Left, unpacked its bear case for Palantir, using OpenAI to show why it ...

Andrew Left argues that investors have overhyped Palantir stock, and its valuation pales in comparison to a true AI leader ...

Short-seller Citron targets PLTR again, using a Databricks comparison to argue the stock is overvalued after its report sent ...

Short-seller Andrew Left is betting against Palantir amid a stunning 144% rally in the shares in 2025. Left says the ...

Shares of Palantir (PLTR) dropped over 9% on Tuesday due to a critical report from short-selling firm Citron Research, which ...

Palantir Technologies Inc (NASDAQ:PLTR) shares are trading lower Wednesday as the stock continues to pull back following a ...

Palantir shares tumbled Tuesday afternoon, extending recent losses as a high-profile short seller fueled worries the stock ...

Andrew Left of Citron Research, which rose to fame for their role in exposing Valeant Pharmaceuticals, has taken to X to voice his concerns over the ruling in the Trump trial. Using Citron ...

The U.S. Securities and Exchange Commission has charged activist short seller Andrew Left and his firm, Citron Capital LLC, with running a $20 million multiyear “scheme to defraud followers by ...

Left's other company, Citron Research, on May 17, 2019, issued a negative tweet on Beyond Meat, which recommended that readers sell the stock and assign it a target price of $65 per share, at a ...